Tu Thomas's Form 4 filing
Inari Medical, Inc. (NARI) · filed Mar 2, 2022
- Accession no.
- 0001562180-22-002139
- Filed
- Mar 2, 2022, 6:24 PM ET
- Trade date
- Feb 28-Mar 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $360.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tu ThomasCIK 0001806426 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | MOption exerciseAcquired | +3,998 | $0.456 | +$1,823.09 | 82,272 | Direct | |
| Feb 28, 2022 | Common Stock | SSaleDisposed | −1,998 | $90.03F2 | −$179,879.94 | 80,274 | Direct | |
| Feb 28, 2022 | Common Stock | SSaleDisposed | −2,000 | $90.00 | −$180,000 | 78,274 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseAcquired | +2 | $0.457 | +$0.91 | 78,276 | Direct | |
| Mar 1, 2022 | Common Stock | SSaleDisposed | −2 | $90.00 | −$180 | 78,274 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Common Stock | MOption exerciseDisposed | −3,998 | $0.457 | −$1,827.09 | 201,586 | Direct | |
| Mar 1, 2022 | Common Stock | MOption exerciseDisposed | −2 | $0.0457 | −$0.09 | 201,584 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $90.00. to $90.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.